Sort by
Refine Your Search
-
Listed
-
Field
-
The Laboratory of Ion Channel Research (https://voetslab.sites.vib.be/en ), led by Prof. Thomas Voets at the VIB–KU Leuven Center for Brain & Disease Research, is a dynamic hub investigating the
-
The Gut-Immune-Brain Axis Lab (Prof. Seppe De Schepper, VIB-UAntwerp) and the Brain and Systems Immunology Lab (Prof. Kiavash Movahedi, VUB) have a vacancy for a full-time (100%) co-joint doctoral
-
The overarching goal of the TOBI-team is to enhance precision cancer management through the development of innovative wet-lab and bioinformatic tools for diagnostic, prognostic, and predictive analysis. Prof
-
looking for a dynamic and highly motivated PhD student. Research topic Whereas mutations are the driving force for adaptive evolution, many genetic alterations exert negative fitness effects. The effect
-
initiative investigating how human-specific features of brain development shape early behavior and neural circuit function in autism spectrum disorders (ASD). This position is a joint effort between the
-
students who are eager to develop and apply artificial intelligence techniques and mechanistic mathematical models to explore fundamental questions in biology. The PhD program is organized in partnership
-
differentiation, shaping the overall course of plant development. Importantly, the synergy and interdependence of hormone signalling pathways are critical for driving cell cycle progression. These coordinated
-
researcher who is passionate about developing automated systems for microbiological research. The ideal candidate has: An MSc degree in bioengineering, biotechnology, microbiology, computer science, mechanical
-
Participation in a large European collaboration State-of-the-art research facilities A dedicated training program to broaden your expertise and enhance your skill set A doctoral scholarship for a period of one
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently